HCM
ABBV icon

HMS Capital Management’s AbbVie ABBV Stock Holding History

HMS Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-47
Closed -$3K – 206
2019
Q2 		$3K Buy
+47
New +$3.69K ﹤0.01% 264
2019
Q1 		– Sell
-1,600
Closed -$148K – 174
2018
Q4 		$148K Sell
1,600
-19,408
-92% -$1.71M 0.07% 158
2018
Q3 		$1.99M Sell
21,008
-176
-0.8% -$16.7K 0.99% 26
2018
Q2 		$1.96M Buy
21,184
+6,964
+49% +$680K 1.11% 20
2018
Q1 		$1.35M Sell
14,220
-9,494
-40% -$1.04M 0.89% 33
2017
Q4 		$2.29M Buy
23,714
+925
+4% +$87.2K 1.71% 9
2017
Q3 		$2.02M Buy
22,789
+579
+3% +$44.1K 1.73% 10
2017
Q2 		$1.61M Buy
22,210
+302
+1% +$20.3K 1.43% 11
2017
Q1 		$1.45M Buy
21,908
+9,931
+83% +$624K 1.32% 18
2016
Q4 		$750K Buy
11,977
+938
+8% +$57.3K 0.78% 58
2016
Q3 		$696K Buy
+11,039
New +$715K 0.69% 63

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HMS Capital Management's ABBV Position: Q3 2019 in Review

HMS Capital Management sold out of AbbVie (ABBV) in Q3 2019, closing a stake of 47 shares — an estimated $3K sold.

HMS Capital Management first reported a position in ABBV in Q3 2016 and held it in 11 quarters. The position peaked at $2.29M in Q4 2017. 2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • HMS Capital Management reported no remaining AbbVie position as of Q3 2019 after selling out during the quarter.
  • HMS Capital Management sold 47 AbbVie shares in Q3 2019, an estimated $3K.
  • HMS Capital Management first reported a position in AbbVie in Q3 2016 and held it in 11 quarters.
  • HMS Capital Management's AbbVie position peaked at $2.29M in Q4 2017.
  • 2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on HMS Capital Management's 13F filing for Q3 2019, filed 15 Oct 2019.